O	0	1	c	c	SYM	O
O	1	2	-	-	:	O
O	2	5	MYC	MYC	NN	B-NP
O	6	15	functions	function	VBZ	B-VP
O	16	18	as	as	IN	B-PP
O	19	20	a	a	DT	B-NP
O	21	30	molecular	molecular	JJ	I-NP
O	31	37	switch	switch	NN	I-NP
O	38	40	to	to	TO	B-VP
O	41	46	alter	alter	VB	I-VP
O	47	50	the	the	DT	B-NP
O	51	59	response	response	NN	I-NP
O	60	62	of	of	IN	B-PP
O	63	68	human	human	JJ	B-NP
B-Cell	69	76	mammary	mammary	JJ	I-NP
I-Cell	77	87	epithelial	epithelial	JJ	I-NP
I-Cell	88	93	cells	cell	NNS	I-NP
O	94	96	to	to	TO	B-PP
O	97	107	oncostatin	oncostatin	NN	B-NP
O	108	109	M	M	NN	I-NP
O	109	110	.	.	.	O

O	112	121	Cytokines	Cytokine	NNS	B-NP
O	122	126	play	play	VBP	B-VP
O	127	129	an	an	DT	B-NP
O	130	139	important	important	JJ	I-NP
O	140	144	role	role	NN	I-NP
O	145	147	in	in	IN	B-PP
O	148	156	creating	create	VBG	B-VP
O	157	159	an	an	DT	B-NP
O	160	172	inflammatory	inflammatory	JJ	I-NP
O	173	189	microenvironment	microenvironment	NN	I-NP
O	189	190	,	,	,	O
O	191	196	which	which	WDT	B-NP
O	197	199	is	be	VBZ	B-VP
O	200	203	now	now	RB	I-VP
O	204	214	considered	consider	VBN	I-VP
O	215	216	a	a	DT	B-NP
O	217	225	hallmark	hallmark	NN	I-NP
O	226	228	of	of	IN	B-PP
B-Cancer	229	235	cancer	cancer	NN	B-NP
O	235	236	.	.	.	O

O	237	245	Although	Although	IN	B-SBAR
B-Cell	246	251	tumor	tumor	NN	B-NP
I-Cell	252	257	cells	cell	NNS	I-NP
O	258	261	can	can	MD	B-VP
O	262	269	exploit	exploit	VB	I-VP
O	270	278	cytokine	cytokine	NN	B-NP
O	279	288	signaling	signaling	NN	I-NP
O	289	291	to	to	TO	B-VP
O	292	299	promote	promote	VB	I-VP
O	300	306	growth	growth	NN	B-NP
O	306	307	,	,	,	O
O	308	316	invasion	invasion	NN	B-NP
O	316	317	,	,	,	O
O	318	321	and	and	CC	O
O	322	332	metastasis	metastasis	NN	B-NP
O	332	333	,	,	,	O
O	334	337	the	the	DT	B-NP
O	338	346	response	response	NN	I-NP
O	347	349	of	of	IN	B-PP
O	350	356	normal	normal	JJ	B-NP
O	357	360	and	and	CC	I-NP
B-Cell	361	373	premalignant	premalignant	JJ	I-NP
I-Cell	374	384	epithelial	epithelial	JJ	I-NP
I-Cell	385	390	cells	cell	NNS	I-NP
O	391	393	to	to	TO	B-PP
O	394	403	cytokines	cytokine	NNS	B-NP
O	404	411	present	present	JJ	B-ADJP
O	412	414	in	in	IN	B-PP
O	415	416	a	a	DT	B-NP
O	417	427	developing	develop	VBG	I-NP
B-Cancer	428	433	tumor	tumor	NN	I-NP
O	434	450	microenvironment	microenvironment	NN	I-NP
O	451	458	remains	remain	VBZ	B-VP
O	459	466	unclear	unclear	JJ	B-ADJP
O	466	467	.	.	.	O

O	468	478	Oncostatin	Oncostatin	NN	B-NP
O	479	480	M	M	NN	I-NP
O	481	482	(	(	(	O
O	482	485	OSM	OSM	NN	B-NP
O	485	486	)	)	)	O
O	486	487	,	,	,	O
O	488	490	an	an	DT	B-NP
O	491	493	IL	IL	NN	I-NP
O	493	494	-	-	HYPH	I-NP
O	494	495	6	6	CD	I-NP
O	496	502	family	family	NN	I-NP
O	503	511	cytokine	cytokine	NN	I-NP
O	512	523	responsible	responsible	JJ	B-ADJP
O	524	527	for	for	IN	B-PP
O	528	533	STAT3	STAT3	NN	B-NP
O	534	544	activation	activation	NN	I-NP
O	544	545	,	,	,	O
O	546	549	has	have	VBZ	B-VP
O	550	554	been	be	VBN	I-VP
O	555	565	implicated	implicate	VBN	I-VP
O	566	568	in	in	IN	B-PP
B-Cancer	569	575	cancer	cancer	NN	B-NP
O	576	587	development	development	NN	I-NP
O	587	588	,	,	,	O
O	589	600	progression	progression	NN	B-NP
O	600	601	,	,	,	O
O	602	610	invasion	invasion	NN	B-NP
O	610	611	,	,	,	O
O	612	615	and	and	CC	O
O	616	626	metastasis	metastasis	NN	B-NP
O	626	627	.	.	.	O

O	628	641	Paradoxically	Paradoxically	RB	B-ADVP
O	641	642	,	,	,	O
O	643	646	OSM	OSM	NN	B-NP
O	647	650	can	can	MD	B-VP
O	651	655	also	also	RB	I-VP
O	656	664	suppress	suppress	VB	I-VP
O	665	668	the	the	DT	B-NP
O	669	675	growth	growth	NN	I-NP
O	676	678	of	of	IN	B-PP
O	679	685	normal	normal	JJ	B-NP
B-Cell	686	691	cells	cell	NNS	I-NP
O	692	695	and	and	CC	O
B-Cell	696	703	certain	certain	JJ	B-NP
I-Cell	704	709	tumor	tumor	NN	I-NP
I-Cell	709	710	-	-	HYPH	B-VP
I-Cell	710	717	derived	derive	VBN	B-NP
I-Cell	718	722	cell	cell	NN	I-NP
I-Cell	723	728	lines	line	NNS	I-NP
O	728	729	.	.	.	O

O	730	735	Using	Use	VBG	B-VP
O	736	744	isogenic	isogenic	JJ	B-NP
O	745	750	human	human	JJ	I-NP
B-Cell	751	758	mammary	mammary	JJ	I-NP
I-Cell	759	769	epithelial	epithelial	JJ	I-NP
I-Cell	770	775	cells	cell	NNS	I-NP
O	776	777	(	(	(	O
B-Cell	777	781	HMEC	HMEC	NNS	B-NP
O	781	782	)	)	)	O
O	783	785	at	at	IN	B-PP
O	786	795	different	different	JJ	B-NP
O	796	802	stages	stage	NNS	I-NP
O	803	805	of	of	IN	B-PP
B-Cancer	806	816	neoplastic	neoplastic	JJ	B-NP
O	817	831	transformation	transformation	NN	I-NP
O	831	832	,	,	,	O
O	833	835	we	we	PRP	B-NP
O	836	841	found	find	VBD	B-VP
O	842	846	that	that	IN	B-SBAR
O	847	850	OSM	OSM	NN	B-NP
O	851	860	signaling	signaling	NN	I-NP
O	861	871	suppressed	suppress	VBD	B-VP
O	872	873	c	c	NN	B-NP
O	873	874	-	-	HYPH	O
O	874	877	MYC	MYC	NN	B-NP
O	878	888	expression	expression	NN	I-NP
O	889	892	and	and	CC	O
O	893	900	engaged	engage	VBD	B-VP
O	901	902	a	a	DT	B-NP
O	903	906	p16	p16	NN	I-NP
O	906	907	-	-	HYPH	B-NP
O	908	911	and	and	CC	I-NP
O	912	915	p53	p53	NN	I-NP
O	915	916	-	-	HYPH	I-NP
O	916	927	independent	independent	JJ	I-NP
O	928	934	growth	growth	NN	I-NP
O	935	941	arrest	arrest	NN	I-NP
O	942	946	that	that	WDT	B-NP
O	947	955	required	require	VBD	B-VP
O	956	961	STAT3	STAT3	NN	B-NP
O	962	970	activity	activity	NN	I-NP
O	970	971	.	.	.	O

O	972	982	Inhibition	Inhibition	NN	B-NP
O	983	985	of	of	IN	B-PP
O	986	991	STAT3	STAT3	NN	B-NP
O	992	1002	activation	activation	NN	I-NP
O	1003	1005	by	by	IN	B-PP
O	1006	1016	expressing	express	VBG	B-VP
O	1017	1018	a	a	DT	B-NP
O	1019	1027	dominant	dominant	JJ	I-NP
O	1027	1028	-	-	HYPH	I-NP
O	1028	1036	negative	negative	JJ	I-NP
O	1037	1042	STAT3	STAT3	NN	I-NP
O	1043	1050	protein	protein	NN	I-NP
O	1051	1053	or	or	CC	O
O	1054	1055	a	a	DT	B-NP
O	1056	1061	STAT3	STAT3	NN	I-NP
O	1061	1062	-	-	HYPH	I-NP
O	1062	1067	shRNA	shRNA	NN	I-NP
O	1068	1077	prevented	prevent	VBD	B-VP
O	1078	1081	the	the	DT	B-NP
O	1082	1085	OSM	OSM	NN	I-NP
O	1085	1086	-	-	HYPH	B-VP
O	1086	1094	mediated	mediate	VBN	B-NP
O	1095	1101	arrest	arrest	NN	I-NP
O	1101	1102	.	.	.	O

O	1103	1105	In	In	IN	B-PP
O	1106	1114	addition	addition	NN	B-NP
O	1114	1115	,	,	,	O
O	1116	1126	expression	expression	NN	B-NP
O	1127	1129	of	of	IN	B-PP
O	1130	1131	c	c	NN	B-NP
O	1131	1132	-	-	HYPH	O
O	1132	1135	MYC	MYC	NN	B-NP
O	1136	1140	from	from	IN	B-PP
O	1141	1142	a	a	DT	B-NP
O	1143	1155	constitutive	constitutive	JJ	I-NP
O	1156	1164	promoter	promoter	NN	I-NP
O	1165	1169	also	also	RB	B-ADVP
O	1170	1179	abrogated	abrogate	VBD	B-VP
O	1180	1183	the	the	DT	B-NP
O	1184	1189	STAT3	STAT3	NN	I-NP
O	1189	1190	-	-	HYPH	B-VP
O	1190	1198	mediated	mediate	VBN	B-NP
O	1199	1205	arrest	arrest	NN	I-NP
O	1205	1206	,	,	,	O
O	1207	1210	and	and	CC	O
O	1211	1221	strikingly	strikingly	RB	B-ADVP
O	1221	1222	,	,	,	O
O	1223	1233	cooperated	cooperate	VBD	B-VP
O	1234	1238	with	with	IN	B-PP
O	1239	1242	OSM	OSM	NN	B-NP
O	1243	1245	to	to	TO	B-VP
O	1246	1253	promote	promote	VB	I-VP
O	1254	1263	anchorage	anchorage	NN	B-NP
O	1263	1264	-	-	HYPH	B-NP
O	1264	1275	independent	independent	JJ	I-NP
O	1276	1282	growth	growth	NN	I-NP
O	1283	1284	(	(	(	O
O	1284	1287	AIG	AIG	NN	B-NP
O	1287	1288	)	)	)	O
O	1288	1289	,	,	,	O
O	1290	1291	a	a	DT	B-NP
O	1292	1300	property	property	NN	I-NP
O	1301	1311	associated	associate	VBN	B-VP
O	1312	1316	with	with	IN	B-PP
O	1317	1326	malignant	malignant	JJ	B-NP
O	1327	1341	transformation	transformation	NN	I-NP
O	1341	1342	.	.	.	O

O	1343	1354	Cooperative	Cooperative	JJ	B-NP
O	1355	1369	transformation	transformation	NN	I-NP
O	1370	1372	by	by	IN	B-PP
O	1373	1374	c	c	NN	B-NP
O	1374	1375	-	-	HYPH	I-NP
O	1375	1378	MYC	MYC	NN	I-NP
O	1379	1382	and	and	CC	I-NP
O	1383	1386	OSM	OSM	NN	I-NP
O	1387	1395	required	require	VBD	B-VP
O	1396	1400	PI3K	PI3K	NN	B-NP
O	1401	1404	and	and	CC	I-NP
O	1405	1408	AKT	AKT	NN	I-NP
O	1409	1418	signaling	signaling	NN	I-NP
O	1418	1419	,	,	,	O
O	1420	1427	showing	show	VBG	B-VP
O	1428	1431	the	the	DT	B-NP
O	1432	1442	importance	importance	NN	I-NP
O	1443	1445	of	of	IN	B-PP
O	1446	1454	multiple	multiple	JJ	B-NP
O	1455	1464	signaling	signaling	NN	I-NP
O	1465	1473	pathways	pathway	NNS	I-NP
O	1474	1484	downstream	downstream	RB	B-ADVP
O	1485	1487	of	of	IN	B-PP
O	1488	1491	the	the	DT	B-NP
O	1492	1495	OSM	OSM	NN	I-NP
O	1496	1504	receptor	receptor	NN	I-NP
O	1505	1507	in	in	IN	B-PP
O	1508	1516	defining	define	VBG	B-VP
O	1517	1520	the	the	DT	B-NP
B-Cell	1521	1529	cellular	cellular	JJ	I-NP
O	1530	1538	response	response	NN	I-NP
O	1539	1541	to	to	TO	B-PP
O	1542	1551	cytokines	cytokine	NNS	B-NP
O	1551	1552	.	.	.	O

O	1553	1558	These	These	DT	B-NP
O	1559	1567	findings	finding	NNS	I-NP
O	1568	1576	identify	identify	VBP	B-VP
O	1577	1578	c	c	NN	B-NP
O	1578	1579	-	-	HYPH	O
O	1579	1582	MYC	MYC	NN	B-NP
O	1583	1585	as	as	IN	B-PP
O	1586	1588	an	an	DT	B-NP
O	1589	1598	important	important	JJ	I-NP
O	1599	1608	molecular	molecular	JJ	I-NP
O	1609	1615	switch	switch	NN	I-NP
O	1616	1620	that	that	WDT	B-NP
O	1621	1627	alters	alter	VBZ	B-VP
O	1628	1631	the	the	DT	B-NP
B-Cell	1632	1640	cellular	cellular	JJ	I-NP
O	1641	1649	response	response	NN	I-NP
O	1650	1652	to	to	TO	B-PP
O	1653	1656	OSM	OSM	NN	B-NP
O	1656	1657	-	-	HYPH	O
O	1657	1665	mediated	mediate	VBN	B-NP
O	1666	1675	signaling	signaling	NN	I-NP
O	1676	1680	from	from	IN	B-PP
B-Cancer	1681	1686	tumor	tumor	NN	B-NP
O	1687	1698	suppressive	suppressive	JJ	B-ADJP
O	1699	1701	to	to	TO	B-PP
B-Cancer	1702	1707	tumor	tumor	NN	B-NP
O	1708	1717	promoting	promoting	NN	I-NP
O	1717	1718	.	.	.	O

